MedFirst Healthcare Services, Inc (4175) Fair Value & Analysis
Healthcare · TW · Market cap 2.1B TWD
Fair value as of: Jul 21, 2026
From 26 valuation models · updated 20 days ago
Share price −1.6% over the past month.
A solid business, screening 29% undervalued on our models.
What matters now
- Solid quality (59/100) at a price below fair value, the discount is the argument here, not the business quality.
- A fairly wide model range (46.86 TWD to 85.71 TWD) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 21, 2026.
How to read this chart
60‑month range 49.74 TWD – 138.53 TWD · fair‑value band 46.86 TWD – 85.71 TWD · the 50.00 TWD price screens below the 64.57 TWD fair value. Dashed = 300-day average. As of Jul 21, 2026.
Analysis
MedFirst Healthcare Services, Inc (4175) currently trades at 50.00 TWD, while our model-based Fair Value estimate is 64.57 TWD, implying the stock looks roughly 29.1% undervalued today. The Quality Score stands at 59/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, MedFirst Healthcare Services, Inc generated revenue of 8.0B TWD at a net margin of 1.6%. Revenue declined 0.7% year over year. It earns a return on equity of 8.4%. Net debt stands at 847M TWD. Fundamentals as of Jul 21, 2026
Our scenario range runs from 46.86 TWD (bear case) to 85.71 TWD (bull case); at 50.00 TWD, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 25% below its 52-week high, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -14% fair-value upside, at 29%, 4175 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 26 models by family
Widest divergence: DCF Models (135.27 TWD) versus Earnings-Based (20.95 TWD). Highest evidence: Growth DCF (80).
Notify me when 4175 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 21, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 56 · Market factors (momentum, volatility) 42
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
MedFirst Healthcare Services, Inc. engages in the sale of medical supplies in Taiwan and China. The company offers diabetes care products, respiratory treatment, incontinence and wound dressing, medical devices, ostomy care, pain relief products, supplements, and rehabilitation products, as well as homecare, childcare, and maternal products.
Full company description
MedFirst Healthcare Services, Inc. engages in the sale of medical supplies in Taiwan and China. The company offers diabetes care products, respiratory treatment, incontinence and wound dressing, medical devices, ostomy care, pain relief products, supplements, and rehabilitation products, as well as homecare, childcare, and maternal products. The company also provides beauty care and oral hygiene products, daily essentials, medical books, cosmetics, and functional food and beverages, as well as wellness food and drugs. In addition, it offers fresh goods, home appliances, pre-orders, linen laundry services, and rental services, as well as prescription drug services. Further, the company is involved in the trade of medical supplies; sale of water electrolysis machine; foreign medical supplies; laundry products; brand agent distribution; and management of shopping malls. It sells products through its retail stores and online. MedFirst Healthcare Services, Inc. was founded in 1990 and is headquartered in Taoyuan City, Taiwan.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
MedFirst Healthcare Services, Inc reported revenue of 8.0B TWD in FY2025 versus 6.5B TWD in FY2021, a compound +5.2%/yr. Reported net income was 156M TWD in FY2025, compounding +23.0%/yr from FY2021.
Watch 4175: get an alert when its fair value changes →
Peer Group
Pharmaceutical Retailers · 61 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Pharmaceutical Retailers median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Pharmaceutical Retailers stocks, each showing price versus our Fair Value estimate (as of Jul 21, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| JD Health International Inc 6618 | HK$39.20 | HK$33.28 | -15% |
| Raia Drogasil S.A RADL3 | R$18.20 | R$15.58 | -14% |
| Yifeng Pharmacy Chain Co 603939 | ¥20.24 | ¥29.07 | +44% |
| DaShenLin Pharmaceutical Group 603233 | ¥17.81 | ¥23.86 | +34% |
| Corporativo Fragua, S.A. FRAGUAB | 463.00 MXN | 821.18 MXN | +77% |
| LBX Pharmacy Chain Joint Stock Company 603883 | ¥11.51 | ¥10.57 | -8% |
| MedPlus Health Services Limited MEDPLUS | ₹690.20 | ₹379.25 | -45% |
| Yixintang Pharmaceutical Group 002727 | ¥11.46 | ¥9.45 | -18% |
| Anhui Huaren Health Pharmaceutical Co 301408 | ¥14.40 | ¥10.05 | -30% |
| Apotea AB APOTEA | kr 74.75 | kr 43.95 | -41% |
Compare MedFirst Healthcare Services, Inc with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is MedFirst Healthcare Services, Inc (4175) overvalued or undervalued?
What is the fair value of 4175?
What is the quality score of 4175?
What is the revenue of MedFirst Healthcare Services, Inc (4175)?
What is the net profit margin of 4175?
Does MedFirst Healthcare Services, Inc pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track MedFirst Healthcare Services, Inc and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.